2022
Depression in transplantation
Zimbrean PC. Depression in transplantation. Current Opinion In Organ Transplantation 2022, 27: 535-545. PMID: 36227755, DOI: 10.1097/mot.0000000000001024.Peer-Reviewed Original ResearchConceptsRisk factorsTransplant recipientsTransplant populationHigher healthcare utilizationOrgan transplant recipientsImprovement of depressionImpact of depressionEffective treatment interventionsRates of depressionSocial risk factorsCognitive behavioral therapyKidney recipientsPosttransplant depressionTransplantation candidatesHealthcare utilizationSupportive therapyClinical statusCommon findingDepression correlatesGeneral populationOrgan donorsTreatment interventionsBehavioral therapyRecipientsDepressionMood Disorders in Transplantation: Bipolar Disorder Spectrum
Dahal R, Zimbrean P. Mood Disorders in Transplantation: Bipolar Disorder Spectrum. 2022, 13-22. DOI: 10.1007/978-3-031-15052-4_2.ChaptersBipolar disorderEnd-stage organ failureNeuropsychiatric adverse effectsRole of psychotropicsOrgan transplant recipientsSolid organ transplantationStandard immunosuppressantsPharmacological managementTransplant outcomesTransplant recipientsOrgan failureDisease burdenBipolar disorder spectrumSuccessful transplantationOrgan transplantationMood disordersGeneral populationTransplantationPatientsAdverse effectsDisorder spectrumDisordersPsychological effectsNonadherenceImmunosuppressants
2019
Chapter 19 Wilson Disease Psychiatric Aspects
Zimbrean P. Chapter 19 Wilson Disease Psychiatric Aspects. 2019, 215-225. DOI: 10.1016/b978-0-12-810532-0.00019-7.Peer-Reviewed Original ResearchQuality of lifeWilson's diseasePsychiatric presentationsGoals of careNewer psychotropic medicationsIrreversible cognitive declineCommon presentationNeurological findingsSymptomatic treatmentPsychotropic medicationsCurrent treatmentGeneral populationPsychiatric aspectsCognitive declineFunctional psychosesWD patientsCognitive deficitsMood instabilitySymptomsTreatmentPresentationSecondary effectsRemissionMedicationsPatientsChapter 14 Psychiatric Symptoms in WD
Zimbrean P. Chapter 14 Psychiatric Symptoms in WD. 2019, 159-170. DOI: 10.1016/b978-0-12-811077-5.00014-1.Peer-Reviewed Original ResearchWilson's diseasePsychiatric presentationsGoals of careNewer psychotropic medicationsSevere side effectsQuality of lifeIrreversible cognitive declineNeurological findingsPatients' qualitySymptomatic treatmentPsychotropic medicationsCurrent treatmentPsychiatric symptomsMood symptomsGeneral populationSide effectsFunctional psychosesCognitive declineWD patientsCognitive deficitsMood instabilitySymptomsTreatmentPresentationRemission
2018
Dialysis: Medical and Psychological Considerations
Hussain F, Zimbrean P. Dialysis: Medical and Psychological Considerations. 2018, 91-102. DOI: 10.1007/978-3-319-94914-7_7.Peer-Reviewed Original ResearchEnd-stage renal diseaseChronic kidney diseaseStage 5 chronic kidney diseaseDiscontinuation of dialysisRenal replacement modalityAge-matched cohortDemand of dialysisRenal diseasePeritoneal dialysisReplacement modalityCenter hemodialysisKidney diseasePatient populationWorse outcomesSleep disordersGeneral populationMortality rateRelevant pharmacologyHome dialysisPsychiatric implicationsMedical considerationsPatientsDialysisIncreased ratesDisease